---
version: 1.0
last_updated: 2026-09-08
project: ATS
owner: docops
category: work-summary
status: confirmed
dependencies:
  - path: REQ-20260908-ATS-003.md
    reason: Approved bounded assessment
  - path: ../agent/WI-20260908-ATS-013-evidence-pack.md
    reason: Independent deployment and document findings
---

# WI-20260908-ATS-013: DocOps Assessment

## Findings

- No repository-owned deployment CI/configuration was found in the bounded inventory: 3,203 tracked paths and zero conventional deployment-manifest matches. Application configuration, acceptance scripts and production procedures do exist; they do not amount to a configured production deployment.
- External-host setup is separately UNKNOWN: no host, runtime, network, secret, provider or mail checks were made. SR-93 remains OPEN.
- Startup is checkout-coupled, not named-branch-pinned: `scripts/acceptance/start.ps1:15,30-36` resolves its own checkout, and `AcceptanceLifecycle.psm1:1248-1265` launches Gradle/Vite there.

## Proposed Corrections

| Current document location | Proposed change, not applied |
|---|---|
| `docs/index.md:73`; `docs/client/testing-guide.md:28-32`; `docs/client/_internal-feature-map.md:60`; `docs/payment/feature-inventory.md:184` | Replace unqualified old p1/no-client claims with the MA-approved central baseline pointer; retain old observations as dated history. |
| `docs/payment/index.md:60,67`; `docs/SR/SR-93.md:92` | Separate the dated `7eae086` receipt from the later `5328482` documentation baseline supplied by MA; do not infer runtime or deployment changes. |
| `docs/client/_internal-feature-map.md:62-64` | Date the old focused-only quality boundary and link subsequent dated quality evidence; do not imply production approval. |

## Preservation And Delivery

- Preserve the historical WI005 table (`docs/payment/index.md:75-87`), dated SR-93 quality/schema evidence and historical branch references. Six directly encountered evidence/audit links were checked: all locally present and Git-tracked; fresh clones of different refs were not tested. MA's README-only default `main` must not be assumed to include them.
- Production target, artifact/ref, HTTPS/proxy, secrets, DB/media recovery, monitoring, scheduler ownership and release approval still require named-target decisions/evidence (`docs/SR/SR-93.md:65-71`).
- Only this summary and the [Evidence Pack](../agent/WI-20260908-ATS-013-evidence-pack.md) were created. No current source/docs or Git/runtime state was changed by DocOps.
- Validation: document validator ran once and PASSed (exit 0; Tier 0, links, 681 traceability IDs and index). Evidence Pack 103/120 lines; summary 37/40. Only result receipts were added afterward. No product tests were run.
- DocOps scope is complete independently. MA owns the separate branch decision register and combined WI013/REQ003 completion; this is not production GO.
